Figure 2From: Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanomaKaplan-Meier curves for time to disease progression (A) and overall survival (B) of patients with metastatic melanoma treated with indicator lesions (n = 16) or treated in the stage IV adjuvant setting (n = 11).Back to article page